Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mabwell (Shanghai) Bioscience Co., Ltd.
Nanjing Leads Biolabs Co.,Ltd
Nanjing Leads Biolabs Co.,Ltd
AstraZeneca
Genmab
Intergroupe Francophone de Cancerologie Thoracique
University Hospital, Lille
HC Biopharma Inc.
Bristol-Myers Squibb
PrECOG, LLC.
Shanghai Hengrui Pharmaceutical Co., Ltd.
CStone Pharmaceuticals